Literature DB >> 2990149

Spinal ganglia and peripheral nerves from a patent with Tay-Sachs disease. Morphological and ganglioside studies.

T Abe, K Ogawa, H Fuziwara, K Urayama, K Nagashima.   

Abstract

We examined the spinal ganglia and peripheral nerves from a patient with Tay-Sachs disease, comparing the other nervous tissues morphologically and lipid-biochemically. The spinal ganglia and peripheral nerves showed numerous membranous cytoplasmic inclusion bodies (MCBs), which are characteristic of GM2-ganglioside storage in the neuronal cell bodies of the patient brains. In spinal ganglia, all neurons and satellite cells around the neurons contained membrane-bound lipid materials. In peripheral nerves, Schwann cells and myelinated axons except for enlarged axons were devoid of MCBs. Major ganglioside stored in both spinal ganglia and peripheral nerve was also GM2-ganglioside. The contents of ganglioside in the spinal ganglia and peripheral nerves were 50 and 10 times more than those from normal tissues, respectively. The spinal cord contained a slightly higher amount of gangliosides than the normal control. The cerebral white matter totally demyelinated in this patient accumulated a much higher amount of gangliosides than the cerebral gray matter. The retinal tissue showed GM2-ganglioside as the major one also.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990149     DOI: 10.1007/bf00688589

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

2.  Genetic leukodystrophies.

Authors:  K Suzuki
Journal:  Trans Am Neurol Assoc       Date:  1976

3.  Gangliosides of human, bovine and rabbit retina.

Authors:  M Holm; J E Månsson; M T Vanier; L Svennerholm
Journal:  Biochim Biophys Acta       Date:  1972-10-05

4.  The characterization of sphingolipids from neurons and astroglia of immature rat brain.

Authors:  T Abe; W T Norton
Journal:  J Neurochem       Date:  1974-11       Impact factor: 5.372

5.  The characterization of sphingolipids of oligodendroglia from calf brain.

Authors:  T Abe; W T Norton
Journal:  J Neurochem       Date:  1979-03       Impact factor: 5.372

6.  Detection, determination, and metabolism in vitro of gangliosides in mammalian sympathetic ganglia.

Authors:  J U Harris; J D Klingman
Journal:  J Neurochem       Date:  1972-05       Impact factor: 5.372

7.  Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component.

Authors:  R W Ledeen; R K Yu; L F Eng
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

8.  I-cell disease (mucolipidosis 11). Pathological and biochemical studies of an autopsy case.

Authors:  K Nagashima; K Sakakibara; H Endo; Y Konishi; N Nakamura; Y Suzuki; T Abe
Journal:  Acta Pathol Jpn       Date:  1977-03

9.  Axonal transport of gangliosides in the goldfish optic nerve.

Authors:  D S Forman; R W Ledeen
Journal:  Science       Date:  1972-08-18       Impact factor: 47.728

10.  Retinal amacrine cell involvement in Tay-Sachs disease.

Authors:  K Nagashima; F Kikuchi; Y Suzuki; T Abe
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

View more
  3 in total

1.  Natural history of infantile G(M2) gangliosidosis.

Authors:  Annette E Bley; Ourania A Giannikopoulos; Doug Hayden; Kim Kubilus; Cynthia J Tifft; Florian S Eichler
Journal:  Pediatrics       Date:  2011-10-24       Impact factor: 7.124

2.  Natural history of Tay-Sachs disease in sheep.

Authors:  Brett Story; Toloo Taghian; Jillian Gallagher; Jey Koehler; Amanda Taylor; Ashley Randle; Kayly Nielsen; Amanda Gross; Annie Maguire; Sara Carl; Siauna Johnson; Deborah Fernau; Elise Diffie; Paul Cuddon; Carly Corado; Sundeep Chandra; Miguel Sena-Esteves; Edwin Kolodny; Xuntian Jiang; Douglas Martin; Heather Gray-Edwards
Journal:  Mol Genet Metab       Date:  2021-08-21       Impact factor: 4.204

3.  AAV gene therapy for Tay-Sachs disease.

Authors:  Terence R Flotte; Oguz Cataltepe; Ajit Puri; Ana Rita Batista; Richard Moser; Diane McKenna-Yasek; Catherine Douthwright; Gwladys Gernoux; Meghan Blackwood; Christian Mueller; Phillip W L Tai; Xuntian Jiang; Scot Bateman; Spiro G Spanakis; Julia Parzych; Allison M Keeler; Aly Abayazeed; Saurabh Rohatgi; Laura Gibson; Robert Finberg; Bruce A Barton; Zeynep Vardar; Mohammed Salman Shazeeb; Matthew Gounis; Cynthia J Tifft; Florian S Eichler; Robert H Brown; Douglas R Martin; Heather L Gray-Edwards; Miguel Sena-Esteves
Journal:  Nat Med       Date:  2022-02-10       Impact factor: 87.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.